Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential
Caitlin M. Dugdale(Brown University), Rochelle P. Walensky(Harvard University), Elaine J. Abrams(ICAP Global Health), Robin Wood(Desmond Tutu HIV Foundation), Kenneth A. Freedberg(Harvard University), Andrea Ciaranello(Harvard University), Landon Myer(University of Cape Town), Paul E. Sax(Brigham and Women's Hospital), Madeline E. Stern(Massachusetts General Hospital), Linda‐Gail Bekker(Desmond Tutu HIV Foundation)
Cited by 70
Related Papers
Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
|Clinical Infectious Diseases|2001|680
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
|Nature|2022|623